BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song H, Ekheden IG, Zheng Z, Ericsson J, Nyrén O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867. [PMID: 26215280 DOI: 10.1136/bmj.h3867] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Cui J, Cui H, Yang M, Du S, Li J, Li Y, Liu L, Zhang X, Li S. Tongue coating microbiome as a potential biomarker for gastritis including precancerous cascade. Protein Cell 2019;10:496-509. [PMID: 30478535 DOI: 10.1007/s13238-018-0596-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
2 Li D, Bautista MC, Jiang SF, Daryani P, Brackett M, Armstrong MA, Hung YY, Postlethwaite D, Ladabaum U. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol. 2016;111:1104-1113. [PMID: 27185078 DOI: 10.1038/ajg.2016.188] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
3 Huang RJ, Hwang JH. Improving the Early Diagnosis of Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:503-17. [PMID: 34053636 DOI: 10.1016/j.giec.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Talebkhan Y, Doozbakhshan M, Saberi S, Esmaeili M, Karami N, Mohajerani N, Abdirad A, Eshagh Hosseini M, Nahvijou A, Mohagheghi MA, Mohammadi M. Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer. Iran Biomed J 2017;21:321-9. [PMID: 27677314 DOI: 10.18869/acadpub.ibj.21.5.321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Olsen I, Yilmaz Ö. Possible role of Porphyromonas gingivalis in orodigestive cancers. J Oral Microbiol 2019;11:1563410. [PMID: 30671195 DOI: 10.1080/20002297.2018.1563410] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 14.7] [Reference Citation Analysis]
6 Zhu SX, Tong XZ, Zhang S. Expression of miR-711 and mechanism of proliferation and apoptosis in human gastric carcinoma. Oncol Lett 2017;14:4505-10. [PMID: 29085447 DOI: 10.3892/ol.2017.6777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
7 Abdelfattah T, Shahab O, Shah TU. Gastric intestinal metaplasia: when to treat? How to treat? Curr Opin Gastroenterol 2021;37:602-8. [PMID: 34432654 DOI: 10.1097/MOG.0000000000000784] [Reference Citation Analysis]
8 Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Michaëlsson K, Neovius M, Stephansson O, Ye W. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol 2016;31:125-36. [PMID: 26769609 DOI: 10.1007/s10654-016-0117-y] [Cited by in Crossref: 492] [Cited by in F6Publishing: 492] [Article Influence: 82.0] [Reference Citation Analysis]
9 Spence AD, Cardwell CR, McMenamin ÚC, Hicks BM, Johnston BT, Murray LJ, Coleman HG. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol 2017;17:157. [PMID: 29228909 DOI: 10.1186/s12876-017-0708-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
10 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68:1545-1575. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 113] [Cited by in F6Publishing: 109] [Article Influence: 37.7] [Reference Citation Analysis]
11 Ndegwa N, Ploner A, Andersson AF, Zagai U, Andreasson A, Vieth M, Talley NJ, Agreus L, Ye W. Gastric Microbiota in a Low-Helicobacter pylori Prevalence General Population and Their Associations With Gastric Lesions. Clin Transl Gastroenterol 2020;11:e00191. [PMID: 32764211 DOI: 10.14309/ctg.0000000000000191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Huang HL, Leung CY, Saito E, Katanoda K, Hur C, Kong CY, Nomura S, Shibuya K. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. BMC Med 2020;18:257. [PMID: 32921305 DOI: 10.1186/s12916-020-01729-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cheung KS, Leung WK. Risk of gastric cancer development after eradication of Helicobacter pyloriWorld J Gastrointest Oncol 2018; 10(5): 115-123 [PMID: 29770171 DOI: 10.4251/wjgo.v10.i5.115] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
15 Sheu BS, Wu MS, Chiu CT, Lo JC, Wu DC, Liou JM, Wu CY, Cheng HC, Lee YC, Hsu PI, Chang CC, Chang WL, Lin JT. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. Helicobacter. 2017;22. [PMID: 28066960 DOI: 10.1111/hel.12368] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
16 Xiao S, Lu H, Xue Y, Cui R, Meng L, Jin Z, Yin Z, Zhou L. Long-Term Outcome of Gastric Mild-Moderate Dysplasia: A Real-World Clinical Experience. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01145-9. [PMID: 34718170 DOI: 10.1016/j.cgh.2021.10.032] [Reference Citation Analysis]
17 Wang R, Chen XZ. Prevalence of atrophic gastritis in southwest China and predictive strength of serum gastrin-17: A cross-sectional study (SIGES). Sci Rep 2020;10:4523. [PMID: 32161305 DOI: 10.1038/s41598-020-61472-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Nieminen A, Kontto J, Puolakkainen P, Virtamo J, Kokkola A. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis. Scand J Gastroenterol. 2019;54:145-151. [PMID: 30700174 DOI: 10.1080/00365521.2019.1566492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
19 Yang T, Wang R, Zhang J, Bao C, Zhang J, Li R, Chen X, Wu S, Wen J, Wei S, Li H, Cai H, Yang X, Zhao Y. Mechanism of berberine in treating Helicobacter pylori induced chronic atrophic gastritis through IRF8-IFN-γ signaling axis suppressing. Life Sci 2020;248:117456. [PMID: 32097666 DOI: 10.1016/j.lfs.2020.117456] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
20 den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten M, Prytz-berset I, Witteman EM, ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCW. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut 2019;68:585-93. [DOI: 10.1136/gutjnl-2017-314498] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
21 Mera RM, Bravo LE, Camargo MC, Bravo JC, Delgado AG, Romero-Gallo J, Yepez MC, Realpe JL, Schneider BG, Morgan DR, Peek RM, Correa P, Wilson KT, Piazuelo MB. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2018;67:1239-1246. [PMID: 28647684 DOI: 10.1136/gutjnl-2016-311685] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 14.2] [Reference Citation Analysis]
22 Shao L, Li P, Ye J, Chen J, Han Y, Cai J, Lu X. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;. [PMID: 29707766 DOI: 10.1002/ijc.31571] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
23 Tsai MC, Wang CC, Lee HL, Peng CM, Yang TW, Chen HY, Sung WW, Lin CC. Health disparities are associated with gastric cancer mortality-to-incidence ratios in 57 countries. World J Gastroenterol 2017; 23(44): 7881-7887 [PMID: 29209129 DOI: 10.3748/wjg.v23.i44.7881] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
24 Segna D, Brusselaers N, Glaus D, Krupka N, Misselwitz B. Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis. Therap Adv Gastroenterol 2021;14:17562848211051463. [PMID: 34777575 DOI: 10.1177/17562848211051463] [Reference Citation Analysis]
25 Waldum HL, Rehfeld JF. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia. Scand J Gastroenterol 2019;54:1118-23. [PMID: 31524029 DOI: 10.1080/00365521.2019.1663446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
26 Esposito G, Dilaghi E, Cazzato M, Pilozzi E, Conti L, Carabotti M, Di Giulio E, Annibale B, Lahner E. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region. Dig Liver Dis 2021;53:467-73. [PMID: 33199230 DOI: 10.1016/j.dld.2020.10.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Isajevs S, Savcenko S, Liepniece-Karele I, Piazuelo MB, Kikuste I, Tolmanis I, Vanags A, Gulbe I, Mezmale L, Samentaev D, Tazedinov A, Samsutdinov R, Belihina T, Igissinov N, Leja M. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia. Virchows Arch 2021. [PMID: 33990867 DOI: 10.1007/s00428-021-03116-3] [Reference Citation Analysis]
28 Quach DT, Hiyama T, Le HM, Nguyen TS, Gotoda T. Use of endoscopic assessment of gastric atrophy for gastric cancer risk stratification to reduce the need for gastric mapping. Scand J Gastroenterol 2020;55:402-7. [PMID: 32223458 DOI: 10.1080/00365521.2020.1740777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Grad C, Pop A, Gaborean E, Grad S, Dumitrascu D. Value of GastroPanel in the diagnosis of atrophic gastritis. Exp Ther Med 2021;22:1347. [PMID: 34630701 DOI: 10.3892/etm.2021.10782] [Reference Citation Analysis]
30 Kim YI, Kook MC, Cho SJ, Lee JY, Kim CG, Joo J, Choi IJ. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages. Helicobacter. 2017;22. [PMID: 28940945 DOI: 10.1111/hel.12442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
31 Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology 2020;158:732-744.e16. [PMID: 31816301 DOI: 10.1053/j.gastro.2019.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
32 Jiang K, Jiang X, Wen Y, Liao L, Liu F. Relationship between long‐term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis. Journal of Gastroenterology and Hepatology 2019;34:1898-905. [DOI: 10.1111/jgh.14759] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
33 Tran-duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2016;14:1706-1719.e5. [DOI: 10.1016/j.cgh.2016.05.018] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 14.7] [Reference Citation Analysis]
34 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X; en representación de la Asociación Española de Gastroenterología, la Sociedad Española de Endoscopia Digestiva y la Sociedad Española de Anatomía Patológica. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol 2021;44:67-86. [PMID: 33252332 DOI: 10.1016/j.gastrohep.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ng AK, Ng PY, Ip A, Cheung KS, Siu CW. Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer. BMJ Open Gastroenterol 2021;8:e000719. [PMID: 34380699 DOI: 10.1136/bmjgast-2021-000719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Chu L, Zhao J, Sheng C, Yue M, Wang F, Song S, Cheng B, Xie G, Fang X. Confocal laser endomicroscopy under propofol-based sedation for early gastric cancer and pre-cancerous lesions is associated with better diagnostic accuracy: a retrospective cohort study in China. BMC Anesthesiol 2021;21:97. [PMID: 33784972 DOI: 10.1186/s12871-021-01312-x] [Reference Citation Analysis]
37 Zhang X, Li M, Chen S, Hu J, Guo Q, Liu R, Zheng H, Jin Z, Yuan Y, Xi Y, Hua B. Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review. Gastroenterology. 2018;155:347-354.e349. [PMID: 29723507 DOI: 10.1053/j.gastro.2018.04.026] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 18.0] [Reference Citation Analysis]
38 Tan MC, Mallepally N, Liu Y, El-Serag HB, Thrift AP. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol 2020;115:381-7. [PMID: 31899705 DOI: 10.14309/ajg.0000000000000498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
39 Thrift AP, Jove AG, Liu Y, Tan MC, El-Serag HB. Associations of Duration, Intensity, and Quantity of Smoking With Risk of Gastric Intestinal Metaplasia. J Clin Gastroenterol 2022;56:e71-6. [PMID: 33337636 DOI: 10.1097/MCG.0000000000001479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Markowski AR, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol 2016; 22(40): 8883-8891 [PMID: 27833379 DOI: 10.3748/wjg.v22.i40.8883] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
41 O’connor A, Bowden A, Farrell E, Weininger J, Crowther S, Mcnamara D, Ridgway P, O’morain C. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body. Dig Dis Sci 2021;66:3470-5. [DOI: 10.1007/s10620-020-06659-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Zhang HP, Yang S, Chen WH, Hu TT, Lin J. The diagnostic value of confocal laser endomicroscopy for gastric cancer and precancerous lesions among Asian population: a system review and meta-analysis. Scand J Gastroenterol. 2017;52:382-388. [PMID: 28078907 DOI: 10.1080/00365521.2016.1275770] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
43 Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24(30): 3313-3329 [PMID: 30122873 DOI: 10.3748/wjg.v24.i30.3313] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
44 Waldum HL, Sagatun L, Mjønes P. Gastrin and Gastric Cancer. Front Endocrinol (Lausanne) 2017;8:1. [PMID: 28144230 DOI: 10.3389/fendo.2017.00001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
45 Romańczyk M, Ostrowski B, Marek T, Romańczyk T, Błaszczyńska M, Budzyń K, Bugajski M, Koziej M, Kajor M, Januszewski K, Zajęcki W, Waluga M, Hartleb M. Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia. J Gastroenterol 2021;56:651-8. [PMID: 33934197 DOI: 10.1007/s00535-021-01790-3] [Reference Citation Analysis]
46 Wu SR, Liu J, Zhang LF, Wang N, Zhang LY, Wu Q, Liu JY, Shi YQ. Lamb’s tripe extract and vitamin B12 capsule plus celecoxib reverses intestinal metaplasia and atrophy: A retrospective cohort study. World J Clin Cases 2021; 9(34): 10472-10483 [PMID: 35004979 DOI: 10.12998/wjcc.v9.i34.10472] [Reference Citation Analysis]
47 Chapelle N, Péron M, Quénéhervé L, Bourget A, Leroy M, Touchefeu Y, Cauchin E, Coron E, Mosnier JF, Matysiak-Budnik T. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Clin Transl Gastroenterol 2020;11:e00237. [PMID: 33512802 DOI: 10.14309/ctg.0000000000000237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zhu C, Wang Y, Cai C, Cai Q. Bacterial Infection and Associated Cancers. In: Cai Q, Yuan Z, Lan K, editors. Infectious Agents Associated Cancers: Epidemiology and Molecular Biology. Singapore: Springer; 2017. pp. 181-91. [DOI: 10.1007/978-981-10-5765-6_11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
49 Duan X, Lian H, Li J, Wu B, Wang W, Wu T, Wang C, Dou Y, Zhou Z, Wang B, Xue L, Wang G. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia. Diagn Pathol 2019;14:61. [PMID: 31221180 DOI: 10.1186/s13000-019-0838-9] [Reference Citation Analysis]
50 Chen X, Wang R, Bao C, Zhang J, Zhang J, Li R, Wu S, Wen J, Yang T, Wei S, Li H, Wei Y, Ren S, Zhao Y. Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR. Eur J Pharmacol 2020;882:173267. [PMID: 32569674 DOI: 10.1016/j.ejphar.2020.173267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Suchecka D, Błaszczyk K, Harasym J, Gudej S, Wilczak J, Gromadzka-ostrowska J. Impact of purified oat 1-3,1-4-β-d-glucan of different molecular weight on alleviation of inflammation parameters during gastritis. Journal of Functional Foods 2017;28:11-8. [DOI: 10.1016/j.jff.2016.10.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
52 Spechler SJ, Merchant JL, Wang TC, Chandrasoma P, Fox JG, Genta RM, Goldenring JR, Hayakawa Y, Kuipers EJ, Lund PK, McKeon F, Mills JC, Odze RD, Peek RM Jr, Pham T, Que J, Rustgi AK, Shaheen NJ, Shivdasani RA, Souza RF, Storz P, Todisco A, Wang DH, Wright NA. A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance. Gastroenterology 2017;153:e6-e13. [PMID: 28583825 DOI: 10.1053/j.gastro.2017.05.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
53 Negovan A, Iancu M, Fülöp E, Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J Gastroenterol 2019; 25(30): 4105-4124 [PMID: 31435167 DOI: 10.3748/wjg.v25.i30.4105] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
54 Kim YI, Park JY, Kim BJ, Hwang HW, Hong SA, Kim JG. Risk of metachronous gastric neoplasm occurrence during intermediate-term follow-up period after endoscopic submucosal dissection for gastric dysplasia. Sci Rep. 2020;10:6747. [PMID: 32317745 DOI: 10.1038/s41598-020-63722-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Lage J, Uedo N, Dinis-Ribeiro M, Yao K. Surveillance of patients with gastric precancerous conditions. Best Pract Res Clin Gastroenterol. 2016;30:913-922. [PMID: 27938786 DOI: 10.1016/j.bpg.2016.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
56 Wang R, Liu K, Chen XZ; SIGES research group. Associations between gastric cancer risk and virus infection other than Epstein-Barr virus: The protocol of a systematic review and meta-analysis based on epidemiological studies. Medicine (Baltimore) 2019;98:e16708. [PMID: 31393376 DOI: 10.1097/MD.0000000000016708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
57 Lam SK, Lau G. Novel treatment for gastric intestinal metaplasia, a precursor to cancer. JGH Open. 2020;4:569-573. [PMID: 32782940 DOI: 10.1002/jgh3.12318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zullo A, Lahner E, Hassan C, Annibale B, Esposito G. Is There an Optimal Age Threshold for Searching for Intestinal Metaplasia on Gastric Mucosa in Western Populations? GE Port J Gastroenterol 2021;28:398-402. [PMID: 34901446 DOI: 10.1159/000516008] [Reference Citation Analysis]
59 Dai YQ, Ye ZD, Huang HH. Long-term effect of Helicobacter pylori eradication combined with folate in patients with chronic atrophic gastritis. Shijie Huaren Xiaohua Zazhi 2017; 25(19): 1777-1782 [DOI: 10.11569/wcjd.v25.i19.1777] [Reference Citation Analysis]
60 Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6-30. [PMID: 27707777 DOI: 10.1136/gutjnl-2016-312288] [Cited by in Crossref: 1166] [Cited by in F6Publishing: 992] [Article Influence: 194.3] [Reference Citation Analysis]
61 Davitkov P, Altayar O, Shah SC, Gawron AJ, Mustafa RA, Sultan S, Morgan DR. Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. Gastroenterology 2020;158:751-9. [PMID: 31887260 DOI: 10.1053/j.gastro.2019.12.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Laird-Fick HS, Saini S, Hillard JR. Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. Postgrad Med J. 2016; May 24. [Epub ahead of print]. [PMID: 27222587 DOI: 10.1136/postgradmedj-2016-133997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Wang C, Zhao D, Shu X, Wang K, Wang T, Lin X, Zhang D, Xia T, Qian S, Tang M, Yang W, Hu A, Zhao Q. Protective effects of all-trans retinoic acid against gastric premalignant lesions by repressing exosomal LncHOXA10-pyruvate carboxylase axis. J Cancer Res Clin Oncol 2021. [PMID: 34632533 DOI: 10.1007/s00432-021-03820-2] [Reference Citation Analysis]
64 Toyoshima O, Nishizawa T, Koike K. Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis. World J Gastroenterol 2020; 26(5): 466-477 [PMID: 32089624 DOI: 10.3748/wjg.v26.i5.466] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
65 Tan MC, Balakrishnan M, Graham DY. Gastric Cancer Worldwide Except Japan. In: Shiotani A, editor. Gastric Cancer. Singapore: Springer; 2019. pp. 17-28. [DOI: 10.1007/978-981-13-1120-8_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
66 Elias E, Targownik LE. The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events. Drugs 2019;79:715-31. [PMID: 30972661 DOI: 10.1007/s40265-019-01110-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
67 Kodaka Y, Futagami S, Tatsuguchi A, Yamawaki H, Sato H, Hashimoto S, Kawagoe T, Ueki N, Nagoya H, Maruki Y, Miyake K, Gudis K, Sakamoto C, Iwakiri K. Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto Classification. Digestion 2017;96:173-83. [DOI: 10.1159/000479864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Ness-Jensen E, Bringeland EA, Mattsson F, Mjønes P, Lagergren J, Grønbech JE, Waldum HL, Fossmark R. Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population-based nested case-control study. Int J Cancer 2021;148:1879-86. [PMID: 33091962 DOI: 10.1002/ijc.33354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol 2019; 25(27): 3546-3562 [PMID: 31367156 DOI: 10.3748/wjg.v25.i27.3546] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
70 Cheung KS, Leung WK. Long-term use of proton-pump inhibitors and risk of gastric cancer: A review of the current evidence. Therap Adv Gastroenterol. 2019;12:1756284819834511. [PMID: 30886648 DOI: 10.1177/1756284819834511] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
71 Coelho MCF, Ribeiro HG, Gomes CGO, Marinho FP, Barbosa AJA, Coelho LGV. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE. Arq Gastroenterol 2021;58:39-47. [PMID: 33909795 DOI: 10.1590/S0004-2803.202100000-08] [Reference Citation Analysis]
72 Huang RJ, Choi AY, Truong CD, Yeh MM, Hwang JH. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions. Gut Liver. 2019;13:596-603. [PMID: 31394893 DOI: 10.5009/gnl19181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
73 Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM Jr, Correa P, Wilson KT. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions. Gastroenterology 2021;160:1106-1117.e3. [PMID: 33220252 DOI: 10.1053/j.gastro.2020.11.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Kadurei F, Alboraie M. Case of gastric intestinal metaplasia in an old patient with previous gastric surgery. BMJ Case Rep 2016;2016:bcr2016216556. [PMID: 27558191 DOI: 10.1136/bcr-2016-216556] [Reference Citation Analysis]
75 Akbari M, Kardeh B, Tabrizi R, Ahmadizar F, Lankarani KB. Incidence Rate of Gastric Cancer Adenocarcinoma in Patients With Gastric Dysplasia: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2019;53:703-10. [PMID: 31415022 DOI: 10.1097/MCG.0000000000001257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
76 Lin S, Gao T, Sun C, Jia M, Liu C, Ma X, Ma A. Association of dietary patterns and endoscopic gastric mucosal atrophy in an adult Chinese population. Sci Rep 2019;9:16567. [PMID: 31719557 DOI: 10.1038/s41598-019-52951-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Chu F, Li Y, Meng X, Li Y, Li T, Zhai M, Zheng H, Xin T, Su Z, Lin J, Zhang P, Ding X. Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N'-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet. Front Physiol 2021;12:733979. [PMID: 34803728 DOI: 10.3389/fphys.2021.733979] [Reference Citation Analysis]
78 Nieminen AA, Kontto J, Puolakkainen P, Virtamo J, Kokkola A. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis. World J Gastroenterol 2020; 26(24): 3447-3457 [PMID: 32655268 DOI: 10.3748/wjg.v26.i24.3447] [Reference Citation Analysis]
79 Trieu JA, Bilal M, Saraireh H, Wang AY. Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA. Dig Dis Sci. 2019;64:1079-1088. [PMID: 30771043 DOI: 10.1007/s10620-019-05526-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
80 Ni Z, Min Y, Han C, Yuan T, Lu W, Ashktorab H, Smoot DT, Wu Q, Wu J, Zeng W, Shi Y. TGR5-HNF4α axis contributes to bile acid-induced gastric intestinal metaplasia markers expression. Cell Death Discov 2020;6:56. [PMID: 32655894 DOI: 10.1038/s41420-020-0290-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Lin N, Yu T, Zheng W, Hu H, Xiang L, Ye G, Zhong X, Ye B, Wang R, Deng W, Li J, Wang X, Han F, Zhuang K, Zhang D, Xu H, Ding J, Zhang X, Shen Y, Lin H, Zhang Z, Kim JJ, Liu J, Hu W, Duan H, Si J. Simultaneous Recognition of Atrophic Gastritis and Intestinal Metaplasia on White Light Endoscopic Images Based on Convolutional Neural Networks: A Multicenter Study. Clin Transl Gastroenterol 2021;12:e00385. [PMID: 34342293 DOI: 10.14309/ctg.0000000000000385] [Reference Citation Analysis]
82 Siregar GA, Parwati I, Achmad TH, Syukriani YF. Association between VEGF-634G>C Gene Polymorphism with Gastric Premalignant Lesions and Serum VEGF Levels in Helicobacter pylori Gastritis Patients. Open Access Maced J Med Sci 2018;6:1328-34. [PMID: 30159051 DOI: 10.3889/oamjms.2018.266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Yan R, Li K, Yuan DW, Wang HN, Zhang Y, Dang CX, Zhu K. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Int J Oncol 2018;53:2566-78. [PMID: 30320337 DOI: 10.3892/ijo.2018.4595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
84 Yan R, Guo Y, Gong Q, Chen M, Guo Y, Yang P, Huang H, Huang H, Huang W, Ma Z, Zheng Z, Tian D, Su M. Microbiological evidences for gastric cardiac microflora dysbiosis inducing the progression of inflammation. J Gastroenterol Hepatol 2020;35:1032-41. [PMID: 31783428 DOI: 10.1111/jgh.14946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Santos E. Current approaches to gastric cancer in Peru and Mexico. Transl Gastroenterol Hepatol 2017;2:55. [PMID: 28616610 DOI: 10.21037/tgh.2017.05.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
86 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
87 Song JH, Kim SG, Jin EH, Lim JH, Yang SY. Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy. Gut Liver 2017;11:612-9. [PMID: 28531911 DOI: 10.5009/gnl16488] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
88 Gu J, Xie S, Wang S, Xue L, Zhou J, Li M, Fan Z, Chen R, Middleton DRS, Hao C, Wang J, Li B, Li X, Wei W. Surveillance of premalignant gastric cardia lesions: A population-based prospective cohort study in China. Int J Cancer 2021;149:1639-48. [PMID: 34181269 DOI: 10.1002/ijc.33720] [Reference Citation Analysis]
89 Zhang LY, Zhang J, Li D, Liu Y, Zhang DL, Liu CF, Wang N, Wu SR, Lu WQ, Guo JZ, Shi YQ. Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study. J Dig Dis 2021;22:282-90. [PMID: 33793080 DOI: 10.1111/1751-2980.12986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Yeoh KG, Tan P. Mapping the genomic diaspora of gastric cancer. Nat Rev Cancer 2021. [PMID: 34702982 DOI: 10.1038/s41568-021-00412-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Chapelle N, Jirka I, Péron M, Quénéhervé L, Cauchin E, Touchefeu Y, Coron E, Mosnier JF, Matysiak-Budnik T. Evaluation of a Phone Call Reminder Strategy in the Surveillance of Patients with Gastric Precancerous Lesions Lost to Follow-Up. Gastrointest Tumors 2020;7:110-6. [PMID: 33173774 DOI: 10.1159/000508873] [Reference Citation Analysis]
92 Da B, Jani N, Gupta N, Jayaram P, Kankotia R, Yao Yu C, Dinis-Ribeiro M, Buxbaum J. High-risk symptoms do not predict gastric cancer precursors. Helicobacter 2019;24:e12548. [PMID: 30412322 DOI: 10.1111/hel.12548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
93 Amieva M, Peek RM. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150:64-78. [PMID: 26385073 DOI: 10.1053/j.gastro.2015.09.004] [Cited by in Crossref: 335] [Cited by in F6Publishing: 302] [Article Influence: 47.9] [Reference Citation Analysis]
94 Venerito M, Link A, Rokkas T, Malfertheiner P. Gastric cancer - clinical and epidemiological aspects. Helicobacter. 2016;21 Suppl 1:39-44. [PMID: 27531538 DOI: 10.1111/hel.12339] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
95 Wei N, Zhou M, Lei S, Zhong Z, Shi R. A meta-analysis and systematic review on subtypes of gastric intestinal metaplasia and neoplasia risk. Cancer Cell Int 2021;21:173. [PMID: 33731114 DOI: 10.1186/s12935-021-01869-0] [Reference Citation Analysis]
96 de Korwin JD. [Helicobacter pylori: When to look for an infection and treat it in adults?]. Rev Med Interne 2021;42:482-91. [PMID: 33648778 DOI: 10.1016/j.revmed.2020.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Chatzopoulou D, Triantafyllou T, Tsamis D, Chrysikos D, Kalles V, Zografos G, Theodorou D. Case presentation of acanthosis nigricans diagnosed with gastric adenocarcinoma. ANZ J Surg 2020;90:182-4. [PMID: 30836438 DOI: 10.1111/ans.15052] [Reference Citation Analysis]
98 Quach DT, Le HM, Nguyen TS, Hiyama T. The Distribution of Incomplete Gastric Intestinal Metaplasia (GIM) Subtype among Biopsy Sites according to the Updated Sydney System and Its Association with GIM Extension. Gastroenterol Res Pract. 2018;2018:4938730. [PMID: 29853861 DOI: 10.1155/2018/4938730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]